Q2 2023 Holdings
Filed 2023-08-14 | 127 holdings | $5.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sinovac Biotech LTD(SVA) | SHS | P8696W104 | $340.0M | 2,718,735 | 6.2% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $212.2M | 620,500 | 3.8% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $183.7M | 8,998,338 | 3.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $182.8M | 3,379,900 | 3.3% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $160.8M | 17,233,668 | 2.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $158.6M | 556,800 | 2.9% |
| Humana Inc(HUM) | COM | 444859102 | $155.9M | 348,700 | 2.8% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $153.8M | 3,375,000 | 2.8% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $140.0M | 1,615,210 | 2.5% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $117.3M | 244,000 | 2.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $112.9M | 14,567,176 | 2.0% |
| Acelyrin Inc | COM | 00445A100 | $111.3M | 5,326,302 | 2.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $109.6M | 4,178,588 | 2.0% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $100.8M | 2,269,637 | 1.8% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $95.2M | 1,488,000 | 1.7% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $89.0M | 2,169,500 | 1.6% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $88.7M | 401,900 | 1.6% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $87.7M | 2,895,632 | 1.6% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $87.7M | 5,156,561 | 1.6% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $87.2M | 186,000 | 1.6% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $84.9M | 162,800 | 1.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $82.9M | 910,200 | 1.5% |
| Stryker Corporation(SYK) | COM | 863667101 | $82.8M | 271,400 | 1.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $79.9M | 3,777,778 | 1.4% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $78.2M | 960,500 | 1.4% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $74.9M | 654,000 | 1.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $74.3M | 321,569 | 1.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $71.2M | 3,950,796 | 1.3% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $71.1M | 22,362,850 | 1.3% |
| Xtant MED Hldgs Inc(XTNT) | COM NEW | 98420P308 | $68.0M | 73,114,592 | 1.2% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $66.7M | 7,619,135 | 1.2% |
| Ikena Oncology Inc | NONVOTING | 000000000 | $66.3M | 11,895,652 | 1.2% |
| R1 RCM Inc(RCM1USD) | COM | 77634L105 | $63.5M | 3,441,000 | 1.2% |
| Si-Bone Inc(SIBN) | COM | 825704109 | $61.9M | 2,292,531 | 1.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $60.9M | 1,514,734 | 1.1% |
| ARS Pharmaceuticals Inc(SPRY) | COM | 82835W108 | $58.6M | 8,740,887 | 1.1% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $58.2M | 165,400 | 1.1% |
| Scpharmaceuticals Inc(SCPH) | COM | 810648105 | $56.7M | 5,559,528 | 1.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $53.0M | 2,530,240 | 1.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $50.3M | 1,007,148 | 0.9% |
| Prelude Therapeutics Inc(PRLD) | COM | 74065P101 | $49.1M | 10,909,256 | 0.9% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $48.6M | 515,000 | 0.9% |
| Natera Inc(NTRA) | COM | 632307104 | $47.4M | 973,581 | 0.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $46.1M | 489,000 | 0.8% |
| The Cigna Group(CI) | COM | 125523100 | $45.2M | 161,000 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $42.2M | 1,096,000 | 0.8% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $42.0M | 4,081,592 | 0.8% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $41.1M | 6,563,077 | 0.7% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $35.7M | 245,000 | 0.6% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $35.2M | 3,322,488 | 0.6% |